Gait analysis in patients with Parkinson's disease and motor fluctuations: Influence of levodopa and comparison with other measures of motor function

Movement Disorders

Volumn 13, Issue 6, 1998, Pages 900-906

  O'Sullivan, John D ^a   Said, Catherine M ^a   Dillon, Louise C ^a   Huffman, Marion ^a   Hughes, Andrew J ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Gait; Levodopa; Motor fluctuations; Parkinson's disease; Rating scales

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DYSKINESIA; FEMALE; GAIT; HUMAN; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SITTING; STANDING; WALKING;

EID: 0031771175     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130607     Document Type: Article

References (9)

1. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease, vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163.
2. Webster DD. Critical analysis of the disability in Parkinson's disease. Modem Treatment 1968;5:257-282.
3. Geminiani G, Cesana BM, Tamma F, et al. Interobserver reliability between neurologists in training of Parkinson's disease rating scales. Mov Disord 1991;6:330-335.
4. Baas H, Stecker K, Fischer PA. Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease. J Neural Transm 1993;5:45-61.
5. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994;9:89-91.
6. Stern GM, Franklyn SE, Imms FJ, Prestidge SP. Quantitative assessments of gait and mobility in Parkinson's disease. J Neural Transm Suppl 1983;19:201-214.
7. Martinez-Martin P, Garcia Urra D, del Ser Quijano T, et al. A new clinical tool for gait evaluation in Parkinson's disease. Clin Neuropharmacol 1997;20:183-194.
8. Bowes SG, Clark PK, Leeman AL, et al. Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa. Br J Clin Pharmacol 1990;30:13-24.
9. Bowes SG, Clark PK, Charlett A, et al. Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypokinesia. Br J Clin Pharmacol 1991;31:295-304.